| Product NDC: | 14537-966 |
| Proprietary Name: | AS |
| Non Proprietary Name: | Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
| Active Ingredient(s): | .03; .042; 1.1; .41; .588; .276 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL & nbsp; Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 14537-966 |
| Labeler Name: | CaridianBCT, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA001214 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020529 |
| Package NDC: | 14537-966-10 |
| Package Description: | 100 mL in 1 BAG (14537-966-10) |
| NDC Code | 14537-966-10 |
| Proprietary Name | AS |
| Package Description | 100 mL in 1 BAG (14537-966-10) |
| Product NDC | 14537-966 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dextrose Monohydrate, Sodium Citrate, Sodium Chloride, Sodium Phosphate, Monobasic, Monohydrate, Citric Acid Monohydrate and Adenine |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20020529 |
| Marketing Category Name | NDA |
| Labeler Name | CaridianBCT, Inc. |
| Substance Name | ADENINE; CITRIC ACID MONOHYDRATE; DEXTROSE MONOHYDRATE; SODIUM CHLORIDE; SODIUM CITRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Strength Number | .03; .042; 1.1; .41; .588; .276 |
| Strength Unit | g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
| Pharmaceutical Classes |